Mayr, C. H.; Sengupta, A.; Asgharpour, S.; Ansari, M.; Pestoni, J. C.; Ogar, P.; Angelidis, I.; Liontos, A.; Rodriguez-Castillo, J. A.; Lang, N. J.et al.; Strunz, M.; Porras-Gonzalez, D.; Gerckens, M.; De Sadeleer, L. J.; Oehrle, B.; Viteri-Alvarez, V.; Fernandez, I. E.; Tallquist, M.; Irmler, M.; Beckers, J.; Eickelberg, O.; Stoleriu, G. M.; Behr, J.; Kneidinger, N.; Wuyts, W. A.; Wasnick, R. M.; Yildirim, A. O.; Ahlbrecht, K.; Morty, R. E.; Samakovlis, C.; Theis, F. J.; Burgstaller, G.; Schiller, H. B.: Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts. EUROPEAN RESPIRATORY JOURNAL 63 (2), 2301326 (2024)
Dzhuraev, G.; Rodriguez-Castillo, J.; Camp, J. R.; Muehlfeld, C.; Seeger, W.; Morty, R. E.: Estimation of Absolute Number of Alveolar Epithelial Type 2 Cells: A Comparison Between Flow Cytometry and Stereology. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 197 (2018)
Solaligue, D. E. S.; Rodriguez-Castillo, J. A.; Ahlbrecht, K.; Morty, R. E.: Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY 313 (6), pp. L1101 - L1153 (2017)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).